Although various markers, such as adenosine deaminase (ADA) activity, serum amyloid A (SAA) levels, and sIL-2r levels, have been used in adults to support diagnosis and monitor disease activity, none of these markers have been studied widely in children with sarcoidosis. This evidence concerns the gene ADA and sarcoidosis.